Výsledky vyhledávání - "Ludovica Conforti"

Effectiveness of SB4 Transition from Originator Etanercept in Rheumatoid Arthritis and Axial Spondyloarthritis: A Subgroup Analysis from the BENEFIT Study

Autor: Nicoletta Luciano, Enrico Fusaro, Maria Chiara Ditto, Aurora Ianniello, Emanuela Bellis, Cosimo Bruni, Ombretta Viapiana, Elisa Gremese, Alberto Migliore, Ester Romoli, Ludovica Conforti, Marcello Govoni, Marco Matucci-Cerinic, Carlo Selmi

Publikováno v: Rheumatology and immunology research. 3(1)

Objectives The pan-European BENEFIT study of patients with stable rheumatoid arthritis (RA) or axial spondyloarthritis (axSpA) who transitioned from reference etanercept to SB4 found no clinically meaningful changes in disease control after transitio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f41c7ac2d80c3960fe8f763ad2ffb1fc
https://pubmed.ncbi.nlm.nih.gov/36467021

Zobrazit plný text záznamu

Topical Application of a Galenical Formulation for the Management of Everolimus-Induced Mucositis in Patients with Metastatic Cancer: a Retrospective Study

Autor: Serafino Conforti, Stefano Minardi, Salvatore Palazzo, Stefania Bilotta, Salvatore Turano, Emmanuelle Vilardo, Ludovica Conforti

Publikováno v: Oncology and Therapy

Introduction Stomatitis is a common and potentially dose-limiting adverse event of the mammalian target of rapamycin (mTOR) inhibitor therapy. To minimize dose reductions or treatment delays that may affect therapeutic outcomes, management includes p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25373e920a0377a87e22ab37aec9848b
https://pubmed.ncbi.nlm.nih.gov/28261655

Zobrazit plný text záznamu

Targeted therapy in renal carcinoma: a case of long-term effect with complete control of toxicity

Autor: Serafino Conforti, Silvia Ceniti, Ludovica Conforti, Salvatore Turano, Stefano Minardi, Salvatore Palazzo

Publikováno v: Tumori. 100(6)

Although advances in imaging techniques have allowed earlier diagnosis of renal cell carcinoma (RCC) in recent decades, one-third of patients who have undergone radical resection of organ-confined disease will eventually develop metastases. The treat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94298829ac24c917335279bb0af1d74d
https://pubmed.ncbi.nlm.nih.gov/25688514

Zobrazit plný text záznamu

Improvement of quality of life in third-line chemotherapy with lapatinib in a case of metastatic breast cancer

Autor: Serafino Conforti, Salvatore Turano, Stefano Minardi, Claudio Locco, Ludovica Conforti, Salvatore Palazzo

Publikováno v: Tumori. 99(3)

We describe a case of a 72-year-old patient suffering from metastatic breast cancer. The disease had progressed slowly and was almost asymptomatic for a significant time. Toxicity, following third-line treatment with lapatinib, was not significant, a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c61c373f6e961a51383a67635be1ec6
https://pubmed.ncbi.nlm.nih.gov/24158085

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání